DENOSUMAB (Prolia®)

Alert: see other clinical indications

Clinical Indication

Osteoporosis

Comments

Full SCA

 

Date of classification

May 2014

Orange

Shared Care Agreement. Higher risk medicines requiring significant regular monitoring which would be initiated by or at the recommendation of a specialist service which may include mental health services, secondary care, tertiary care, community providers, private providers and GPs with a specialist interest.